Skip to main content

Table 1 Participant characteristics and ReStore Exosuit Sizing

From: The ReWalk ReStore™ soft robotic exosuit: a multi-site clinical trial of the safety, reliability, and feasibility of exosuit-augmented post-stroke gait rehabilitation

Study SubjectStroke TypeSide of ParesisSexAge (y)Chronicity (y)Height (in)Weight (lbs)Walking Speed (m/s)bAssistive DeviceCalf Wrap SizeLiner SizeInsole SizeLateral Support
1aIschemicLeftFemale4811.974.02160.92AFO & CaneSmallSmallLargeYes
2aHemorrhagicRightFemale361.871.01641.21Ankle BraceMediumMediumMediumYes
3aUnknownRightMale506.272.01801.38NoneMediumMediumMediumYes
4aIschemicRightFemale6532.767.01281.14AFO & CaneSmallSmallMediumNo
5aIschemicRightFemale4713.468.51130.95AFO & CaneSmallSmallMediumNo
6aHemorrhagicLeftMale624.965.01651.09CaneSmallSmallMediumNo
7aIschemicLeftMale670.666.01740.77RollatorMediumMediumMediumNo
8aHemorrhagicLeftFemale4912.765.01550.91NoneMediumMediumSmallNo
9aIschemicLeftFemale456.964.02010.72AFOSmallSmallSmallNo
10aHemorrhagicLeftMale5320.665.02140.96AFOMediumMediumLargeNo
11aHemorrhagicLeftFemale4211.463.51770.99NoneLargeLargeMediumNo
12aIschemicLeftFemale551.364.01800.79AFO & CaneMediumMediumMediumNo
13aIschemicRightFemale721.163.01401.08NoneMediumMediumSmallNo
14IschemicLeftMale475.874.02460.87AFOLargeLargeLargeNo
15aIschemicLeftFemale702.264.01600.29AFOSmallSmallMediumNo
16aIschemicLeftMale6113.871.01880.35WalkAide & CaneMediumSmallLargeYes
17aHemorrhagicRightFemale4618.465.02200.54WalkAide & CaneLargeLargeMediumNo
18aIschemicRightMale621.172.02251.14AFOLargeLargeLargeNo
19aIschemicLeftFemale571.864.01420.11AFO & CaneSmallSmallMediumYes
20aHemorrhagicLeftMale506.869.21410.68NoneMediumSmallLargeNo
21aHemorrhagicLeftMale553.271.01630.50NoneSmallSmallLargeNo
22aIschemicRightFemale272.164.01570.90NoneLargeLargeSmallNo
23aIschemicLeftMale680.973.01941.00AFO & CaneSmallMediumLargeNo
24aHemorrhagicRightMale694.769.51690.56AFOLargeMediumLargeNo
25aIschemicLeftFemale5211.865.01350.91AFOSmallSmallSmallNo
26aIschemicRightMale662.369.01900.99AFO & CaneLargeMediumLargeNo
27HemorrhagicLeftMale596.769.51631.00NoneMediumMediumLargeNo
28IschemicLeftMale669.066.72490.74AFO & CaneExtra LargeLargeLargeNo
29aIschemicRightFemale505.364.81810.51AFO & CaneLargeMediumMediumNo
30HemorrhagicRightFemale336.965.51521.12NoneMediumMediumMediumNo
31IschemicLeftMale5514.567.31620.72AFOSmallSmallMediumYes
32IschemicRightMale6416.272.02360.98AFOMediumMediumLargeNo
33aHemorrhagicRightMale367.568.32500.88AFOLargeLargeMediumNo
34aIschemicLeftMale669.468.02330.73AFO & CaneLargeLargeLargeNo
35aHemorrhagicLeftMale607.070.61631.10CaneMediumSmallLargeNo
36IschemicRightMale673.467.71750.38Cane & RollatorMediumMediumMediumNo
37aIschemicLeftMale4612.970.11790.85NoneMediumMediumMediumYes
38aHemorrhagicLeftMale501.574.02110.63CaneMediumMediumLargeNo
39IschemicLeftMale530.470.01960.58CaneMediumMediumMediumNo
40aIschemicRightMale360.671.02310.95NoneLargeLargeMediumNo
41aIschemicLeftMale601.766.01790.96NoneMediumMediumSmallNo
42aHemorrhagicLeftMale686.067.01780.50CaneMediumMediumLargeNo
43aIschemicRightFemale560.963.01630.93AFOSmallSmallSmallYes
44aIschemicRightMale669.872.01990.89AFOMediumMediumMediumNo
  1. aN = 36 subset of study participants who completed all planned study visits and were included in the analysis of secondary and exploratory endpoints
  2. bUsual walking speed assessed at baseline